LivaNova (LIVN) Total Current Liabilities (2015 - 2026)
LivaNova (LIVN) posted Total Current Liabilities of $762.5 million for Q1 2026, down 5.64% sequentially from $808.1 million in Q4 2025, and up 2.82% YoY from $741.6 million in Q1 2025.
LivaNova (LIVN) Total Current Liabilities (2015 - 2026) Analysis & Trends
LivaNova has reported Total Current Liabilities for 12 years, with the latest figure at $762.5 million in Q1 2026.
- Quarterly Total Current Liabilities rose 2.82% year-over-year to $762.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $762.5 million (up 2.82% YoY) and the FY2025 annual result came in at $808.1 million, up 106.08% from the prior year.
- Total Current Liabilities eased to $762.5 million in Q1 2026 per LIVN's latest filing, from $808.1 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $827.6 million in Q3 2025 and troughed at $263.9 million in Q2 2022.
- A 5-year average of $453.3 million and a median of $324.4 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities slumped 62.42% in 2022, then soared 172.98% in 2025.
- Over 5 years, Total Current Liabilities stood at $297.4 million in 2022, then gained by 12.64% to $335.0 million in 2023, then climbed by 17.06% to $392.1 million in 2024, then surged by 106.08% to $808.1 million in 2025, then retreated by 5.64% to $762.5 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $762.5 million, $808.1 million, and $827.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 1.28 Bn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 707.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 707.00 Mn |
| Mar 31, 2026 | 762.48 Mn |
| Dec 31, 2025 | 808.07 Mn |
| Sep 30, 2025 | 827.59 Mn |
| Jun 30, 2025 | 827.10 Mn |
| Mar 31, 2025 | 741.57 Mn |
| Dec 31, 2024 | 392.13 Mn |
| Sep 30, 2024 | 324.40 Mn |
| Jun 30, 2024 | 302.99 Mn |
| Mar 31, 2024 | 327.77 Mn |
| Dec 31, 2023 | 334.98 Mn |
| Sep 30, 2023 | 295.40 Mn |
| Jun 30, 2023 | 288.16 Mn |
| Mar 31, 2023 | 316.13 Mn |
| Dec 31, 2022 | 297.40 Mn |
| Sep 30, 2022 | 288.02 Mn |
| Jun 30, 2022 | 263.89 Mn |
| Mar 31, 2022 | 307.91 Mn |
| Dec 31, 2021 | 696.97 Mn |
| Sep 30, 2021 | 658.47 Mn |